SeaStar Medical Revenue and Competitors
Estimated Revenue & Valuation
- SeaStar Medical's estimated annual revenue is currently $5.8M per year.
- SeaStar Medical's estimated revenue per employee is $251,000
Employee Data
- SeaStar Medical has 23 Employees.
- SeaStar Medical grew their employee count by 5% last year.
SeaStar Medical's People
| Name | Title | Email/Phone |
|---|
SeaStar Medical Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $7.3M | 29 | -6% | N/A | N/A |
#2 | $5.3M | 21 | -28% | N/A | N/A |
#3 | $2.5M | 10 | -17% | N/A | N/A |
#4 | $11.5M | 46 | 5% | N/A | N/A |
#5 | $5.5M | 22 | -33% | N/A | N/A |
#6 | $10.8M | 43 | 0% | N/A | N/A |
#7 | $30.4M | 121 | -10% | N/A | N/A |
#8 | $61.5M | 245 | 4% | N/A | N/A |
#9 | $3.3M | 13 | -13% | N/A | N/A |
#10 | $27.4M | 109 | N/A | N/A | N/A |
What Is SeaStar Medical?
SeaStar Medical is a commercial stage medical device company focused on developing novel immunomodulating technologies to address life-threatening medical conditions. By providing innovative medical solutions for patients with inflammatory diseases, SeaStar seeks to mitigate organ injury and save lives.
keywords:N/A
N/A
Total Funding
23
Number of Employees
$5.8M
Revenue (est)
5%
Employee Growth %
N/A
Valuation
N/A
Accelerator
SeaStar Medical News
SeaStar Medical has agreed to go public in the U.S. via a merger with special purpose acquisition company LMF Acquisition Opportunities...
SeaStar Medical is developing extracorporeal therapies to reduce the consequences of excessive inflammation on vital organs. Advertisement. "We...
Denver-based SeaStar Medical is a privately-held medical technology company that is focusing on redefining how extracorporeal therapies may...
Other Companies in Denver
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1.7M | 23 | -4% | N/A |
#2 | $3.1M | 23 | -21% | $30.4M |
#3 | $2.3M | 23 | N/A | N/A |
#4 | $2.4M | 23 | 5% | N/A |
#5 | $2.1M | 23 | 15% | N/A |